No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
HUGE FSD Pharma
- 0.1470
- +0.0100+7.31%
Close Jul 2 16:00 ET
- 0.1430
- -0.0040-2.72%
Post 19:59 ET
6.19MMarket Cap-588P/E (TTM)
0.1525High0.1300Low2.22MVolume0.1365Open0.1370Pre Close318.84KTurnover5.97%Turnover RatioLossP/E (Static)42.10MShares1.679952wk High0.51P/B5.47MFloat Cap0.130052wk Low--Dividend TTM37.20MShs Float14.0000Historical High--Div YieldTTM16.43%Amplitude0.1300Historical Low0.1430Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Sector Update: Health Care Stocks Decline in Late Afternoon Trading
Health care stocks were retreating late Friday afternoon, with the NYSE Health Care Index down 0.3% and the Health Care Select Sector SPDR Fund (XLV) shedding 0.4%. The iShares Biotechnology ETF (IBB)
FSD Pharma $2 Million Arbitration Award Upheld by Federal Court Against Former CEO
FSD Pharma's (HUGE) former board chairman and chief executive owes more than $2.2 million, plus interest, to the company, after a federal court confirmed a November 2022 arbitration award. Former FSD
FSD Pharma Wins Court Judgment Against Former CEO, Dr. Raza Bokhari
FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting
Express News | FSD Pharma Shares Are Trading Higher After the Company Entered Into an Exclusive Option Agreement With the University of Southern California to Evaluate Dietary Supplement Technology for Commercialization
Express News | FSD Pharma Enters Exclusive Option Agreement With University Of Southern California To Evaluate Dietary Supplement Technology For Commercialization
Weekly Roundup on the Cannabis Sector & Psychedelic Sector Week of 6/2/24
Comments
FSD Pharma, Inc. secures a decisive legal victory, confirming an arbitration award of $3,059,998 plus interest against Dr. Raza Bokhari, who presently holds the position of Chairman and CEO at Medicus Pharma Ltd.
FSD Pharma, Inc., a biopharmaceutical company known for its dedication to the development of innovative treatments for neurodegenerative and metabolic disorders as well as alcohol misuse disorders, recently emerged victor...
FSD Pharma, Inc., a biopharmaceutical company known for its dedication to the development of innovative treatments for neurodegenerative and metabolic disorders as well as alcohol misuse disorders, recently emerged victor...
1
$FSD Pharma(HUGE.US$
GARBAGE
GARBAGE
1
2
$FSD Pharma(HUGE.US$ come on baby!
1
$FSD Pharma(HUGE.US$ FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, today announces that on June 27, 2024, the United States District Court for the Eastern District of Pennsylvania confirmed FSD Pharma, Inc.'s motion for entry of judgment is granted and judgment is entered in favour of FSD Pharma and against Dr. Raza Bo...
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg